Guangzhou Innogen Pharm Grp Co
医疗健康 · 生物科技
Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drug engaged in the research, development and commercialization of pharmaceutical products. The company's products are used for the treatment of metabolic diseases, including diabetes, obesity and overweight, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China.
MARKET 市值 4.74B HKD 52W HK$9.73 – HK$74
EODHD · Q 2025-12-31 · 同步 2026-06-04
QUALITY PEG — 营收 YoY 0.0%
ROE -36.9% 营业利润率 -292.5% 净利润率 -259.6%
⚠ 基本面数据已 41 天未刷新